202 related articles for article (PubMed ID: 28892144)
1. Development and Applications of Patient-Derived Xenograft Models in Humanized Mice for Oncology and Immune-Oncology Drug Discovery.
Verma B; Ritchie M; Mancini M
Curr Protoc Pharmacol; 2017 Sep; 78():14.41.1-14.41.12. PubMed ID: 28892144
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived xenografts as tools in pharmaceutical development.
Izumchenko E; Meir J; Bedi A; Wysocki PT; Hoque MO; Sidransky D
Clin Pharmacol Ther; 2016 Jun; 99(6):612-21. PubMed ID: 26874468
[TBL] [Abstract][Full Text] [Related]
3. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
4. Patient-Derived Xenograft Models in Cancer Research: Methodology, Applications, and Future Prospects.
Aslani S; Saad MI
Methods Mol Biol; 2024; 2806():9-18. PubMed ID: 38676792
[TBL] [Abstract][Full Text] [Related]
5. Patient-Derived Bladder Cancer Xenografts.
Bernardo C; Santos LL
Methods Mol Biol; 2018; 1655():169-175. PubMed ID: 28889386
[TBL] [Abstract][Full Text] [Related]
6. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.
Xu X; Kumari R; Zhou J; Chen J; Mao B; Wang J; Zheng M; Tu X; An X; Chen X; Zhang L; Tian X; Wang H; Dong X; Bao Z; Guo S; Ouyang X; Shang L; Wang F; Yan X; Zhang R; Vries RGJ; Clevers H; Li QX
PLoS One; 2023; 18(1):e0279821. PubMed ID: 36602988
[TBL] [Abstract][Full Text] [Related]
7. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
[TBL] [Abstract][Full Text] [Related]
8. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
9. Towards precision oncology with patient-derived xenografts.
Zanella ER; Grassi E; Trusolino L
Nat Rev Clin Oncol; 2022 Nov; 19(11):719-732. PubMed ID: 36151307
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived xenograft models: an emerging platform for translational cancer research.
Hidalgo M; Amant F; Biankin AV; Budinská E; Byrne AT; Caldas C; Clarke RB; de Jong S; Jonkers J; Mælandsmo GM; Roman-Roman S; Seoane J; Trusolino L; Villanueva A
Cancer Discov; 2014 Sep; 4(9):998-1013. PubMed ID: 25185190
[TBL] [Abstract][Full Text] [Related]
11. The application of zebrafish patient-derived xenograft tumor models in the development of antitumor agents.
Li X; Li M
Med Res Rev; 2023 Jan; 43(1):212-236. PubMed ID: 36029178
[TBL] [Abstract][Full Text] [Related]
12. A Humanized Patient-Derived Xenograft Model for Pancreatic Cancer.
Lundy J
Methods Mol Biol; 2024; 2806():91-100. PubMed ID: 38676798
[TBL] [Abstract][Full Text] [Related]
13. Humanized Mouse Models for Immuno-oncology Drug Discovery.
Kumari R; Feuer G; Bourré L
Curr Protoc; 2023 Aug; 3(8):e852. PubMed ID: 37552031
[TBL] [Abstract][Full Text] [Related]
14. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
[TBL] [Abstract][Full Text] [Related]
15. Humanized mouse models for anti-cancer therapy.
Baietti MF; Leucci E
Methods Cell Biol; 2024; 183():317-333. PubMed ID: 38548416
[TBL] [Abstract][Full Text] [Related]
16. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
Kumari R; Xu X; Li HQ
Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
[TBL] [Abstract][Full Text] [Related]
17. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
[TBL] [Abstract][Full Text] [Related]
18. Molecular and clinical implementations of ovarian cancer mouse avatar models.
Zayed AA; Mandrekar SJ; Haluska P
Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
[TBL] [Abstract][Full Text] [Related]
19. China plans large center for PDX models.
Cancer Discov; 2014 Feb; 4(2):136-7. PubMed ID: 24501285
[TBL] [Abstract][Full Text] [Related]
20. Modeling Tumor Immunology and Immunotherapy in Mice.
Buqué A; Galluzzi L
Trends Cancer; 2018 Sep; 4(9):599-601. PubMed ID: 30149876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]